Biomarkers Market, by Product Type (Biomarker Test Kits, and Biomarker Analyzers), By Disease Indication (Cancer, Cardiovascular Disorder, Infectious Disease, Neurological Disorder, Immunological Disorder and Others), by Application (Diagnosis, Drug Discovery and Development, and Others ), By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, and Diagnostic Laboratories), and by Geography - Global Forecast, 2022 - 2028
Biomarkers are used for diagnosis and drug development, as these biomarkers can indicate diseases in the body. Furthermore, biomarkers can be any specific cells, molecules, genes or gene products, enzymes or hormones. Biomarker-based test are precise and rapid, which help in early prediction of susceptibility, prognosis, diagnosis, and treatment of disease. Hence, increasing research and development activities for identifying new biomarkers to diagnose or treat diseases is expected to be major factor growth of the market.
Biomarker are required for personalized medicine as it helps to identify the unique characteristics of the disease and helps to tailor medicine according to the need of patients. Hence, to cater to demand for personalized medicines, pharmaceutical companies are investing in R&D, which is expected to lead to identification of novel biomarkers, thus aiding in growth of the market.
Market Dynamics
The global biomarkers market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel biomarker. For instance, in February 2018, FDA granted marketing authorization to Banyan Biomarkers, Inc. for the first diagnostic blood test for traumatic brain injury named Banyan BTI. Such innovations, targeting different indications, is expected to drive biomarkers market growth in the near future.
However, investment required for discovering a biomarker is high, due to the cumbersome biomarker validation, and testing process, which hinders growth of the biomarkers market.
Key features of the study:
This report provides in-depth analysis of the biomarkers market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global biomarkers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
Key companies covered as a part of this study include Abbott Laboratories, Medtronic, BG Medicine, Inc., F. Hoffman LA Roche Ltd., Seimens Healthnineers, Nexus-DX, Qiagen N.V., and Lifesign LLC.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
The global biomarkers market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for biomarkers market, research and consulting firms, new entrants and financial analysts.
Detailed Segmentation:
Global Biomarkers Market, By Product Type:
Biomarker Test Kits
Biomarker Analyzers
Global Biomarkers Market, By Disease Indication:
Cancer
Cardiovascular Disorder
Infectious Disease
Neurological Disorder
Immunological Disorder
Others
Global Biomarkers Market, By Application:
Diagnosis
Drug Discovery and Development
Others
Global Biomarkers Market, By End User:
Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories
Global Biomarkers Market, By Region:
North America
North America Biomarkers Market, By Disease Indication:
Biomarker Test Kits
Biomarker Analyzer
North America Biomarkers Market, By Disease Indication:
Cancer
Cardiovascular Disorder
Infectious Disease
Neurological Disorder
Immunological Disorder
Others
North America Biomarkers Market, By Application:
Diagnosis
Drug Discovery and Development
Others
North America Biomarkers Market, By End User
Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories
North America Biomarkers Market, By Country
U.S.
Canada
Europe
Europe Biomarkers Market, By Disease Indication:
Biomarker Test Kits
Biomarker Analyzer
Europe Biomarkers Market, By Disease Indication:
Cancer
Cardiovascular Disorder
Infectious Disease
Neurological Disorder
Immunological Disorder
Others
Europe Biomarkers Market, By Application:
Diagnosis
Drug Discovery and Development
Others
Europe Biomarkers Market, By End User
Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories
Europe Biomarkers Market, By Country
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Asia Pacific Biomarkers Market, By Disease Indication:
Biomarker Test Kits
Biomarker Analyzer
Asia Pacific Biomarkers Market, By Disease Indication:
Cancer
Cardiovascular Disorder
Infectious Disease
Neurological Disorder
Immunological Disorder
Others
Asia Pacific Biomarkers Market, By Application:
Diagnosis
Drug Discovery and Development
Others
Asia Pacific Biomarkers Market, By End User
Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories
Asia Pacific Biomarkers Market, By Country
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Latin America Biomarkers Market, By Disease Indication:
Biomarker Test Kits
Biomarker Analyzer
Latin America Biomarkers Market, By Disease Indication:
Cancer
Cardiovascular Disorder
Infectious Disease
Neurological Disorder
Immunological Disorder
Others
Latin America Biomarkers Market, By Application:
Diagnosis
Drug Discovery and Development
Others
Latin America Biomarkers Market, By End User
Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories
Latin America Biomarkers Market, By Country
Brazil
Mexico
Rest of Latin America
Middle East
Middle East Biomarkers Market, By Disease Indication:
Biomarker Test Kits
Biomarker Analyzer
Middle East Biomarkers Market, By Disease Indication:
Cancer
Cardiovascular Disorder
Infectious Disease
Neurological Disorder
Immunological Disorder
Others
Middle East Biomarkers Market, By Application:
Diagnosis
Drug Discovery and Development
Others
Middle East Biomarkers Market, By End User
Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories
Middle East Biomarkers Market, By Country
GCC
Israel
Rest of Middle East
Africa
Africa Biomarkers Market, By Disease Indication:
Biomarker Test Kits
Biomarker Analyzer
Africa Biomarkers Market, By Disease Indication:
Cancer
Cardiovascular Disorder
Infectious Disease
Neurological Disorder
Immunological Disorder
Others
Africa Biomarkers Market, By Application:
Diagnosis
Drug Discovery and Development
Others
Africa Biomarkers Market, By End User
Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories
Africa Biomarkers Market, By Country
North Africa
Central Africa
South Africa
Company Profiles
Abbott Laboratories *
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Medtronic
BG Medicine, Inc.
Hoffman LA Roche Ltd.
Seimens Healthnineers
Nexus-DX
Qiagen N.V.
Lifesign LLC
“*” marked represents similar segmentation in other categories in the respective section.
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Disease Indication
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Epidemiology
- Biomarker Development Pipeline
- FDA Biomarker Qualification Program
- Qualified Biomarker By FDA
- Reimbursement Scenario
- PEST Analysis
- 4. Global Biomarkers Market, By Product Type, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Biomarker Test Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Biomarker Analyzers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 5. Global Biomarkers Market, By Disease Indication, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cardiovascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Neurological Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Immunological Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 6. Global Biomarkers Market, By Application, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 7. Global Biomarkers Market, By End User, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- 8. Global Biomarkers Market, By Region, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Countries, 2017 - 2028, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Countries, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Latin America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Countries, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Countries, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Countries, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Countries, 2017 - 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
- 9. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Medtronic
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- BG Medicine, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- F.Hoffman LA Roche Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Seimens Healthnineers
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Nexus-DX
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Qiagen N.V.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Lifesign LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Analyst Views
- 10. Section
- References
- Research Methodology
- About Us and Sales Contact
- *Browse 45 market data tables and 37 figures on "Biomarkers Market - Global forecast to 2028”.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook